Cancer Council Australia

Join our network

Facebook Twitter Instagram
Pinterest Youtube RSS

Larger Text Smaller Text Print

Immunotherapy



What is immunotherapy?

Immunotherapy is a type of cancer treatment which assists the body’s immune system to fight cancer. 


What is the immune system?

The immune system is made up of a network of cells and organs and is designed to protect the body from threats such as infections, toxins and abnormal cell development. The immune system recognises when a foreign organism, such as a germ, enters the body and attacks it to stop if from harming the body.

Lymphocytes (white blood cells) are a key part of the immune system. There are two main types:

  • B-cells which fight bacteria and viruses.
  • T-cells which help control the immune system and help B-cells make antibodies.

The immune system usually prevents cancers from developing because of its ability to detect and eliminate abnormal cell growth. Sometimes the body’s natural immune system may not be strong enough to fight the cell growth that causes cancer. Cancer cells may also change over time, which can allow them to escape the immune system.


How does immunotherapy work?

There are different kinds of immunotherapy and they work in different ways. Immunotherapy can boost the immune system to work better against cancer or remove barriers to the immune system attacking the cancer.


Types of immunotherapy

Checkpoint inhibitors

Proteins called ‘checkpoints’, on the surface of T-cells can stop the immune system from attacking cancer cells. Checkpoint inhibitors are drugs designed to block these proteins to enable the T-cells to recognise and destroy cancer cells. These type of drugs are currently the most widely used form of immunotherapy. Some are subsidised on the Pharmaceutical Benefits Scheme.

Immune stimulants

Some immunotherapy treatments aim to stimulate the immune system so it reactivates and attacks cancer cells.


When is immunotherapy used?  

Surgery, chemotherapy and radiotherapy are still the most widely used cancer treatments but checkpoint immunotherapy is likely to benefit some people with some types of cancer.

In Australia immunotherapy has been predominantly used for the following cancers:


How is immunotherapy treatment given?

How often and how long you receive immunotherapy may depend on:

  • the type of immunotherapy
  • the type of cancer
  • how advanced the cancer is
  • how you respond to treatment
  • the side effects you may experience.

Checkpoint inhibitors are usually given with an injection into a vein (intraveneously).

When immunotherapy is used to treat some melanoma cases, a cream called imiquimond may be applied directly to the affected area.

Sometimes more than one type of immunotherapy drug is prescribed. Immunotherapy drugs appear to keep working for varying periods of time and in some cases can keep working long after other treatments are no longer used.


What are the side effects of immunotherapy?

Side effects from immunotherapy can vary depending on the type of treatment you receive and how your body responds. The side effects of checkpoint immunotherapy are different from those of other cancer treatments.

Common side effects include:

  • fatigue
  • skin rash
  • diarrhoea
  • abdominal pain
  • dry eyes
  • joint pain.

Rare side effects include:

  • headaches
  • changes in vision
  • shortness of breath and coughing
  • yellowing of the eyes
  • thyroid related issues
  • severe abdominal pain.

Sources

Understanding Immunotherapy fact sheet, Cancer Council Australia, ©2017.

Top

For more information

For support and information on cancer and cancer-related issues, call Cancer Council 13 11 20. This is a confidential service.

Booklets 

ncludes additional information on clinical trials in Australia as well as other types of research, making decisions around participating in research, and contact details for professional bodies involved in clinical trials. 

How you can help

You can support Cancer Council by:

  • volunteering your time
  • participating in an event or
  • making a donation to help fund our cancer research, education and support services.

This page was last updated on: Tuesday, September 5, 2017